SHIP negatively regulates Flt3L-derived dendritic cell generation and positively regulates MyD88-independent TLR-induced maturation

Journal of Leukocyte Biology

Volumn 88, Issue 5, 2010, Pages 925-935

  Antignano, Frann ^a   Ibaraki, Mariko ^a   Ruschmann, Jens ^a,b   Jagdeo, Julienne ^a   Krystal, Gerald ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cytokines; Differentiation; Maturation; T cell activation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD135 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLYCOPROTEIN P 15095; INTERLEUKIN 12; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; SHIP PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVATION; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CROSSES, GENETIC; DENDRITIC CELLS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORIC MONOESTER HYDROLASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; T-LYMPHOCYTES;

EID: 78649615595     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1209825     Document Type: Article

References (58)

1. Heath, W. R., Belz, G. T., Behrens, G. M., Smith, C. M., Forehan, S. P., Parish, I. A., Davey, G. M., Wilson, N. S., Carbone, F. R., Villadangos, J. A. (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199, 9-26.
2. Shortman, K., Naik, S. H. (2007) Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30.
3. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., Steinman, R. M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702.
4. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N., Schuler, G. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92.
5. Xu, Y., Zhan, Y., Lew, A. M., Naik, S. H., Kershaw, M. H. (2007) Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J. Immunol. 179, 7577-7584.
6. Brasel, K., De Smedt, T., Smith, J. L., Maliszewski, C. R. (2000) Generation of murine dendritic cells from Flt3-ligand-supplemented bone marrow cultures. Blood 96, 3029-3039.
7. Weigel, B. J., Nath, N., Taylor, P. A., Panoskaltsis-Mortari, A., Chen, W., Krieg, A. M., Brasel, K., Blazar, B. R. (2002) Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Blood 100, 4169-4176.
8. Brawand, P., Fitzpatrick, D. R., Greenfield, B. W., Brasel, K., Maliszewski, C. R., De Smedt, T. (2002) Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 169, 6711-6719.
9. Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X. L., Trinchieri, G., O'Garra, A., Liu, Y. J. (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953-958.
10. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174, 6592-6597.
11. Boonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G., Liu, Y. J., O'Garra, A. (2003) Flexibility of mouse classical and plasmacytoidderived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential Toll-like receptor ligation. J. Exp. Med. 197, 101-109.
12. Kapsenberg, M. L. (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 3, 984-993.
13. Mazzoni, A., Segal, D. M. (2004) Controlling the Toll road to dendritic cell polarization. J. Leukoc. Biol. 75, 721-730.
14. Pasare, C., Medzhitov, R. (2004) Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6, 1382-1387.
15. Akira, S., Uematsu, S., Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
16. Beutler, B. (2004) Inferences, questions and possibilities in Toll-like receptor signaling. Nature 430, 257-263. (Pubitemid 38902439)
17. Hoebe, K., Beutler, B. (2008) Forward genetic analysis of TLR-signaling pathways: an evaluation. Adv. Drug Deliv. Rev. 60, 824-829.
18. Iwasaki, A., Medzhitov, R. (2004) Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5, 987-995.
19. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
20. Mellman, I., Steinman, R. M. (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106, 255-258.
21. Koyasu, S. (2003) The role of PI3K in immune cells. Nat. Immunol. 4, 313-319.
22. Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., Waterfield, M. D. (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535-602.
23. Hazeki, K., Nigorikawa, K., Hazeki, O. (2007) Role of phosphoinositide 3-kinase in innate immunity. Biol. Pharm. Bull. 30, 1617-1623.
24. Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., Koyasu, S. (2002) PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat. Immunol. 3, 875-881.
25. Fukao, T., Koyasu, S. (2003) PI3K and negative regulation of TLR signaling. Trends Immunol. 24, 358-363.
26. Krystal, G. (2000) Lipid phosphatases in the immune system. Semin. Immunol. 12, 397-403.
27. Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y., Lucas, D. M. (2000) Structure, function, and biology of SHIP proteins. Genes Dev. 14, 505-520.
28. Kuo, C. C., Lin, W. T., Liang, C. M., Liang, S. M. (2006) Class I and III phosphatidylinositol 3′-kinase play distinct roles in TLR signaling pathway. J. Immunol. 176, 5943-5949.
29. Sly, L. M., Ho, V., Antignano, F., Ruschmann, J., Hamilton, M., Lam, V., Rauh, M. J., Krystal, G. (2007) The role of SHIP in macrophages. Front. Biosci. 12, 2836-2848.
30. An, H., Xu, H., Zhang, M., Zhou, J., Feng, T., Qian, C., Qi, R., Cao, X. (2005) Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. Blood 105, 4685-4692.
31. Fang, H., Pengal, R. A., Cao, X., Ganesan, L. P., Wewers, M. D., Marsh, C. B., Tridandapani, S. (2004) Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173, 360-366.
32. Parsa, K. V., Ganesan, L. P., Rajaram, M. V., Gavrilin, M. A., Balagopal, A., Mohapatra, N. P., Wewers, M. D., Schlesinger, L. S., Gunn, J. S., Tridandapani, S. (2006) Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS Pathog. 2, e71.
33. Sly, L. M., Hamilton, M. J., Kuroda, E., Ho, V. W., Antignano, F. L., Omeis, S. L., van Netten-Thomas, C. J., Wong, D., Brugger, H. K., Williams, O., Feldman, M. E., Houseman, B. T., Fiedler, D., Shokat, K. M., Krystal, G. (2009) SHIP prevents lipopolysaccharide from triggering an anti-viral response in mice. Blood 113, 2945-2954.
34. Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H., Krystal, G. (2004) LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21, 227-239. (Pubitemid 39094052)
35. Damen, J. E., Wakao, H., Miyajima, A., Krosl, J., Humphries, R. K., Cutler, R. L., Krystal, G. (1995) Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and STAT5 activation. EMBO J. 14, 5557-5568.
36. Neill, L., Tien, A. H., Rey-Ladino, J., Helgason, C. D. (2007) SHIP-deficient mice provide insights into the regulation of dendritic cell development and function. Exp. Hematol. 35, 627-639.
37. Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., Penninger, J. M. (1999) SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev. 13, 786-791.
38. Beutler, B. A. (2009) TLRs and innate immunity. Blood 113, 1399-1407.
39. Beutler, B., Eidenschenk, C., Crozat, K., Imler, J. L., Takeuchi, O., Hoffmann, J. A., Akira, S. (2007) Genetic analysis of resistance to viral infection. Nat. Rev. Immunol. 7, 753-766.
40. Lou, Y., Liu, C., Kim, G. J., Liu, Y. J., Hwu, P., Wang, G. (2007) Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses. J. Immunol. 178, 1534-1541.
41. Bailey-Bucktrout, S. L., Caulkins, S. C., Goings, G., Fischer, J. A., Dzionek, A., Miller, S. D. (2008) Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 180, 6457-6461.
42. Colonna, M., Trinchieri, G., Liu, Y. J. (2004) Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226.
43. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., Akira, S. (2003) Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640-643. (Pubitemid 36927946)
44. Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Muhlradt, P. F., Sato, S., Hoshino, K., Akira, S. (2001) Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167, 5887-5894.
45. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., Taniguchi, T. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772-777.
46. Deane, J. A., Fruman, D. A. (2004) Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu. Rev. Immunol. 22, 563-598.
47. Weichhart, T., Saemann, M. D. (2008) The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann. Rheum. Dis. 67, iii70-iii74.
48. Guiducci, C., Ghirelli, C., Marloie-Provost, M. A., Matray, T., Coffman, R. L., Liu, Y. J., Barrat, F. J., Soumelis, V. (2008) PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J. Exp. Med. 205, 315-322.
49. Polumuri, S. K., Toshchakov, V. Y., Vogel, S. N. (2007) Role of phosphatidylinositol- 3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fcγ receptor ligation in murine macrophages. J. Immunol. 179, 236-246.
50. Liu, Y. J. (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306.
51. Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J., Pitha, P. M. (1998) Regulation of type I interferon gene expression by interferon regulatory factor- 3. J. Biol. Chem. 273, 2714-2720.
52. Taniguchi, T., Ogasawara, K., Takaoka, A., Tanaka, N. (2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655.
53. Aksoy, E., Vanden Berghe, W., Detienne, S., Amraoui, Z., Fitzgerald, K. A., Haegeman, G., Goldman, M., Willems, F. (2005) Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-κB activation and IFN-β synthesis downstream of Toll-like receptor 3 and 4. Eur. J. Immunol. 35, 2200-2209.
54. Cao, W., Manicassamy, S., Tang, H., Kasturi, S. P., Pirani, A., Murthy, N., Pulendran, B. (2008) Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat. Immunol. 9, 1157-1164.
55. O'Sullivan, B., Thomas, R. (2003) CD40 and dendritic cell function. Crit. Rev. Immunol. 23, 83-107.
56. O'Sullivan, B., Thomas, R. (2003) Recent advances on the role of CD40 and dendritic cells in immunity and tolerance. Curr. Opin. Hematol. 10, 272-278.
57. Orabona, C., Grohmann, U., Belladonna, M. L., Fallarino, F., Vacca, C., Bianchi, R., Bozza, S., Volpi, C., Salomon, B. L., Fioretti, M. C., Romani, L., Puccetti, P. (2004) CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5, 1134-1142.
58. Antignano, F., Ibaraki, M., Kim, C., Ruschmann, J., Zhang, A., Helgason, C. D., Krystal, G. (2010) SHIP is required for dendritic cell maturation. J. Immunol. 184, 2805-2813.